H-VPYGSFKHV-OH

Ref. 3D-PP46551

Información del producto

• Nombre: H-VPYGSFKHV-OH
• Sinónimos: NH2-Val-Pro-Tyr-Gly-Ser-Phe-Lys-His-Val-OH

Descripción

Peptide H-VPYGSFKHV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VPYGSFKHV-OH include the following: The Final N-Terminal Trimming of SPC HLA - J Immunol, 2002 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=3fcdbf53fcf0fea74f35206a45a0835c6d9d0946 Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells S Morel, F Levy, O Burlet-Schiltz, F Brasseur - Immunity, 2000 - cell.comhttps://www.cell.com/immunity/pdf/S1074-7613(00)80163-6.pdf The cytoplasmic peptidase DPP9 is rate-limiting for degradation of proline-containing peptides R Geiss-Friedlander , N Parmentier, U Möller - Journal of biological , 2009 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)38389-7/abstract 264 MASS SPECTROMETRY: MODIFIED PROTEINS AND GLYCOCONJUGATES [11] O BURLET-SCHILTZ - : Modified Proteins and , 2005 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=jFpnZTmZmngC&oi=fnd&pg=PA264&dq=(%22H-VPYGSFKHV-OH%22+OR+%22NH2-Val-Pro-Tyr-Gly-Ser-Phe-Lys-His-Val-OH%22+OR+%22VPYGSFKHV%22)+AND+peptide&ots=tXWYLrsQ6-&sig=z1dz1Gd_AFhQBSOt9RzCSxeq7Fw The use of mass spectrometry to identify antigens from proteasome processing O Burlet-Schiltz, S Claverol, JE Gairin - Methods in Enzymology, 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0076687905050111 A recyclable assay to analyze the NH2-terminal trimming of antigenic peptide precursors L Burri, C Servis, L Chapatte, F Levy - Protein expression and purification, 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1046592802005077 Preclinical development of dipeptidyl peptidase IV inhibitor alogliptin: a brief overview KVL Parsa , M Pal - Expert Opinion on Drug Discovery, 2011 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1517/17460441.2011.588695 Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunity J Dannull, DT Lesher, R Holzknecht - Blood, The Journal , 2007 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/110/13/4341/103257 Advances in understanding the expression and function of dipeptidyl peptidase 8 and 9 H Zhang , Y Chen, FM Keane, MD Gorrell - Molecular Cancer Research, 2013 - AACRhttps://aacrjournals.org/mcr/article-abstract/11/12/1487/89283 The SUMO1-E67 interacting loop peptide is an allosteric inhibitor of the dipeptidyl peptidases 8 and 9 E Pilla, M Kilisch, C Lenz , H Urlaub - Journal of Biological , 2013 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)48610-7/abstract Puromycin-sensitive aminopeptidase limits MHC class I presentation in dendritic cells but does not affect CD8 T cell responses during viral infections CF Towne, IA York , J Neijssen , ML Karow - The Journal of , 2008 - journals.aai.orghttps://journals.aai.org/jimmunol/article/180/3/1704/75825 New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors C Cui, X Tian , L Wei, Y Wang, K Wang - Frontiers in , 2022 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fphar.2022.1002871/full

• Marca: Biosynth